Skip to main content
. 2023 Feb 22;12:e77562. doi: 10.7554/eLife.77562

Table 2. Estimation of the direct impacts of COVID-19 on non-respiratory conditions.

Cause of Death No. estimated excess deaths (95% prediction interval) % of excess deaths directly attributable to COVID-19 (95% prediction interval)*
All-cause 1,065,200 (909,800–121,8000) 84% (65, 94)
Alzheimer’s 25,300 (12,600–37,600) 70% (45, 89)
Diabetes 24,700 (15,900–33,300) 70% (45, 93)
Heart diseases 51,300 (7,400–94,300) 73% (32, 94)
Cerebrovascular diseases 16,600 (5,300–27,800) 26% (−17, 62)
External causes 102,800 (81,400–123,700) −48% (−64, −23)
Cancer 4,300 (−18,100–26,500) N/A
*

Regression estimates of the direct impact of COVID-19 on cause-specific excess mortality, where weekly cause-specific excess mortality is regressed against COVID-19 intensity, strength of interventions, and ICU occupancy, using gam models. Estimates are based on comparison of predictions from the full model with counterfactual predictions where the COVID-19 term is set to zero.

COVID-19 intensity is significant but negatively associated with excess mortality from external causes, hence the estimated attributable fraction is negative.

COVID-19 intensity is not retained in the cancer model.